- Home
- RBKB vs BCAB Comparison
RBKB vs BCAB Comparison
Compare RBKB & BCAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RBKB
- BCAB
- Stock Information
- Founded
- RBKB 1860
- BCAB 2007
- Country
- RBKB United States
- BCAB United States
- Employees
- RBKB N/A
- BCAB N/A
- Industry
- RBKB Banks
- BCAB Medicinal Chemicals and Botanical Products
- Sector
- RBKB Finance
- BCAB Health Care
- Exchange
- RBKB Nasdaq
- BCAB Nasdaq
- Market Cap
- RBKB 92.6M
- BCAB 101.0M
- IPO Year
- RBKB 2019
- BCAB 2020
- Fundamental
- Price
- RBKB $9.63
- BCAB $1.56
- Analyst Decision
- RBKB
- BCAB Buy
- Analyst Count
- RBKB 0
- BCAB 2
- Target Price
- RBKB N/A
- BCAB $5.00
- AVG Volume (30 Days)
- RBKB 7.5K
- BCAB 1.1M
- Earning Date
- RBKB 10-24-2024
- BCAB 11-07-2024
- Dividend Yield
- RBKB N/A
- BCAB N/A
- EPS Growth
- RBKB N/A
- BCAB N/A
- EPS
- RBKB N/A
- BCAB N/A
- Revenue
- RBKB $29,243,000.00
- BCAB $11,000,000.00
- Revenue This Year
- RBKB N/A
- BCAB N/A
- Revenue Next Year
- RBKB N/A
- BCAB N/A
- P/E Ratio
- RBKB N/A
- BCAB N/A
- Revenue Growth
- RBKB N/A
- BCAB N/A
- 52 Week Low
- RBKB $6.10
- BCAB $1.14
- 52 Week High
- RBKB $9.81
- BCAB $4.02
- Technical
- Relative Strength Index (RSI)
- RBKB 65.77
- BCAB 36.97
- Support Level
- RBKB $9.46
- BCAB $2.02
- Resistance Level
- RBKB $9.74
- BCAB $2.53
- Average True Range (ATR)
- RBKB 0.25
- BCAB 0.24
- MACD
- RBKB 0.04
- BCAB -0.05
- Stochastic Oscillator
- RBKB 87.67
- BCAB 5.85
About RBKB Rhinebeck Bancorp Inc.
Rhinebeck Bancorp Inc is the holding company for Rhinebeck Bank which provides a full range of banking and financial services to consumer and commercial customers. Financial services, including investment advisory and financial product sales, are offered through a division of the Bank doing business as Rhinebeck Asset Management (RAM). The Bank's primary business activity is accepting deposits from the general public and using those funds to originate indirect automobile loans (automobile loans referred by automobile dealerships), commercial real estate loans (which include multi-family real estate loans and commercial construction loans), commercial business loans and one- to four-family residential real estate loans, and to purchase investment securities.
About BCAB BioAtla Inc.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.